SLNO
Soleno Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +30.0% ·
Aktienfluss +30.0% ·
neue Nettopositionen +20.0%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q1 2026 | 81 | -6 | 38.38M | $1.28B | +6 | −12 |
| Q4 2025 | 86 | 0 | 43.97M | $2.04B | +1 | −1 |
| Q3 2025 | 17 | -1 | 29.19M | $1.97B | — | −1 |
| Q2 2025 | 15 | -1 | 21.84M | $1.83B | +1 | −2 |
| Q1 2025 | 13 | +4 | 13.32M | $951.87M | +4 | — |
| Q4 2024 | 9 | 0 | 8.99M | $404.33M | — | — |
| Q3 2024 | 8 | 0 | 6.39M | $322.73M | +2 | −2 |
| Q2 2024 | 8 | — | 4.85M | $197.82M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 4.39M | +58.2% | $313.86M | 0.6% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.40M | +47.2% | $171.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 2.40M | +47.2% | $171.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 1.58M | +62.1% | $112.61M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.58M | +62.1% | $112.61M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passiv) | 1.17M | -13.2% | $83.54M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 916.00K | Neu | $65.45M | 0.2% | New | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Wellington Management ✦ | 693.64K | -11.3% | $49.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Millennium Management ✦ | 679.29K | +42.5% | $48.54M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passiv) | 615.74K | +2.8% | $44.00M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passiv) | 615.74K | +2.8% | $44.00M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Capital World Investors ✦ | 464.83K | Neu | $33.21M | 0.0% | New | 1 | SEC ↗ |
| 19 | Soros Fund Management ✦ | 270.66K | Neu | $19.34M | 0.5% | New | 1 | SEC ↗ |
| 20 | Marshall Wace ✦ | 123.75K | -69.0% | $8.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Marshall Wace ✦ | 123.75K | -69.0% | $8.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 16.67K | Neu | $1.19M | 0.0% | New | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 3.11K | -71.0% | $222,425 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 3.11K | -71.0% | $222,425 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 3.11K | -71.0% | $222,425 | 0.0% | ▼ Trim | 3 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Point72 Asset Management | $65.45M | 0.2% |
| Capital World Investors | $33.21M | 0.0% |
| Soros Fund Management | $19.34M | 0.5% |
| D. E. Shaw & Co. | $1.19M | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 224 Inhaber, 55.22M Anteile, $1.81B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.